Clarivate Plc (NYSE:CLVT) was rated a Hold by William Blair analyst Andrew Nicholas, who highlighted strong Q2 results with revenue and EPS exceeding expectations. Although the stock price dropped post-release due to lack of major updates on strategic review, growth areas include academia, government, life sciences, and healthcare.

The company provides data, analytics, and workflow solutions for academia, government, intellectual property, and life sciences sectors. While CLVT shows investment potential, risks include academic and government budget cuts and decreased US federal spending. Consider other AI stocks for greater upside potential and lower downside risk.

William Blair analyst Andrew Nicholas noted upsides and risks for Clarivate Plc (NYSE:CLVT), mentioning recurring revenue increases and segment growth. However, risks include academic and government budget cuts, as well as reduced US federal spending. Despite strong Q2 results, the stock price dropped due to lack of major strategic review updates.

Read more at Yahoo Finance: William Blair Maintained a Hold Rating on Clarivate Plc (CLVT)